Search research articles
Contact Us
Filters
Showing results (1-10 of 54) with videos related to
Page
of 6
Sort By:
Current Topics in Medicinal Chemistry
|
October 27, 2005
DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agents
Klaus Pors, Laurence H Patterson
Drug Discovery Today
|
September 27, 2014
Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?
Klaus Pors, Jan S Moreb
Expert Opinion on Therapeutic Patents
|
May 16, 2009
Microtubule stabilising agents for cancer chemotherapy
Ying Zhao, Wei-Shuo Fang, Klaus Pors
Current Topics in Medicinal Chemistry
|
November 12, 2009
Chemical and biological explorations of the family of CC-1065 and the duocarmycin natural products
Nandita Ghosh, Helen M Sheldrake, Mark Searcey, et al.
Drug Discovery Today
|
May 12, 2015
Refining the chemical toolbox to be fit for educational and practical purpose for drug discovery in the 21st Century
Marco Lolli, Sarah Narramore, Colin W G Fishwick, et al.
Drug Discovery Today
|
November 24, 2020
How can the potential of the duocarmycins be unlocked for cancer therapy?
Zoë Jukes, Goreti Ribeiro Morais, Paul M Loadman, et al.
Journal of Digital Imaging
|
September 5, 2023
Deep Transfer Learning-Based Approach for Glucose Transporter-1 (GLUT1) Expression Assessment
Maisun Mohamed Al Zorgani, Hassan Ugail, Klaus Pors, et al.
AAPS Pharmscitech
|
March 20, 2026
Innovative Nanocarriers of Sorafenib in the Optimisation of Therapeutic Outcome: Challenges and Applications in Breast Cancer
Nishtha Chaurawal, Amalia Ruiz Estrada, Klaus Pors, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
September 5, 2025
Cancer stem cells in focus: Deciphering the dynamic functional landscape of stemness in cancer
Gabriel C Nwokolo, Trivadi Sundaram Ganesan, Klaus Pors, et al.
Cancers
|
March 13, 2024
The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma
Enric Arasanz Picher, Muhammad Wahajuddin, Stefan Barth, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 54) with videos related to
Sort By:
Page
of 6
Current Topics in Medicinal Chemistry
|
October 27, 2005
DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agents
Klaus Pors, Laurence H Patterson
Drug Discovery Today
|
September 27, 2014
Aldehyde dehydrogenases in cancer: an opportunity for biomarker and drug development?
Klaus Pors, Jan S Moreb
Expert Opinion on Therapeutic Patents
|
May 16, 2009
Microtubule stabilising agents for cancer chemotherapy
Ying Zhao, Wei-Shuo Fang, Klaus Pors
Current Topics in Medicinal Chemistry
|
November 12, 2009
Chemical and biological explorations of the family of CC-1065 and the duocarmycin natural products
Nandita Ghosh, Helen M Sheldrake, Mark Searcey, et al.
Drug Discovery Today
|
May 12, 2015
Refining the chemical toolbox to be fit for educational and practical purpose for drug discovery in the 21st Century
Marco Lolli, Sarah Narramore, Colin W G Fishwick, et al.
Drug Discovery Today
|
November 24, 2020
How can the potential of the duocarmycins be unlocked for cancer therapy?
Zoë Jukes, Goreti Ribeiro Morais, Paul M Loadman, et al.
Journal of Digital Imaging
|
September 5, 2023
Deep Transfer Learning-Based Approach for Glucose Transporter-1 (GLUT1) Expression Assessment
Maisun Mohamed Al Zorgani, Hassan Ugail, Klaus Pors, et al.
AAPS Pharmscitech
|
March 20, 2026
Innovative Nanocarriers of Sorafenib in the Optimisation of Therapeutic Outcome: Challenges and Applications in Breast Cancer
Nishtha Chaurawal, Amalia Ruiz Estrada, Klaus Pors, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer
|
September 5, 2025
Cancer stem cells in focus: Deciphering the dynamic functional landscape of stemness in cancer
Gabriel C Nwokolo, Trivadi Sundaram Ganesan, Klaus Pors, et al.
Cancers
|
March 13, 2024
The Capacity of Drug-Metabolising Enzymes in Modulating the Therapeutic Efficacy of Drugs to Treat Rhabdomyosarcoma
Enric Arasanz Picher, Muhammad Wahajuddin, Stefan Barth, et al.
Page
of 6